AI assistant
DEXCOM INC — Director's Dealing 2020
Apr 1, 2020
30198_dirs_2020-04-01_95cea93a-6021-4e9e-9157-42c2179c8470.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-30
Reporting Person: Selvaraj Shelly Ramasamy (SVP Information Technology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-30 | Common Stock | S | 1214 | $271.7875 | Disposed | 25794 | Direct |
Footnotes
F1: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020.